A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve
Clinical trial NCT01110707 · COMPLETED
Trial details
- NCT number
- NCT01110707
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-10
- Primary completion
- 2006-11-15
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.